share_log

HC Wainwright & Co. Maintains Buy on Rani Therapeutics Hldgs, Lowers Price Target to $12

HC Wainwright & Co. Maintains Buy on Rani Therapeutics Hldgs, Lowers Price Target to $12

HC Wainwright & Co.维持对Rani Therapeutics Hldgs的买入,将目标股价下调至12美元
Moomoo 24/7 ·  03/25 06:06

HC Wainwright & Co. analyst Mitchell Kapoor maintains Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy and lowers the price target from $16 to $12.

HC Wainwright & Co. 分析师米切尔·卡普尔维持Rani Therapeutics Hldgs(纳斯达克股票代码:RANI)的买入并将目标股价从16美元下调至12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发